Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

People with HIV receiving suppressive antiretroviral therapy show typical antibody durability after dual COVID-19 vaccination, and strong third dose responses

medRxiv(2022)10.1101/2022.03.22.22272793Source: DataRank Database

People with HIV receiving suppressive antiretroviral therapy show typical antibody durability after dual COVID-19 vaccination, and strong third dose responses is a research paper published in medRxiv (2022). On theSindex it has a DataRank of 0. It has been cited 20 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access20 citations

Download PDF

Cite:

Linked data & code

gisaid

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)OA: greenTopics (17)IDs (PubMed, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (42)

Francis Mwimanzi ORCID,Peter K. Cheung ORCID,Yurou Sang,Fatima Yaseen,Gisele Umviligihozo ORCID

Live enrichment

PubMed:35350205 OpenAlex:https://openalex.org/W4220756647

Wellcome Trust

Grant: 107752/Z/15/Z

Canadian Institutes of Health Research

Grant: unidentified

unidentified

Wellcome Trust

Grant: 107752

Sub-Saharan African Network for TB/HIV research Excellence (SANTHE)

greenLicense: cc-by-nd

repositoryhttps://www.medrxiv.org/content/medrxiv/early/2022/03/23/2022.03.22.22272793.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2022.03.22.22272793

repositoryhttps://doi.org/10.1101/2022.03.22.22272793

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35350205

Fields of Study

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesImmune responses and vaccinations0303 health sciences03 medical and health sciences

Keywords

Human immunodeficiency virus (HIV)Coronavirus disease 2019 (COVID-19)VirologyMedicineVaccinationAntiretroviral therapyDual (grammatical number)AntibodyImmunologyViral loadInternal medicineArticle

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: No poverty